{
    "eid": "2-s2.0-85032934701",
    "title": "Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B \u2217 13:01 allele in the Thai population",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Molecular Medicine",
            "@code": "1313"
        },
        {
            "$": "General Pharmacology",
            "@code": "3000"
        },
        {
            "$": "Genetics (clinical)",
            "@code": "2716"
        },
        {
            "$": "Molecular Biology",
            "@code": "1312"
        },
        {
            "$": "Genetics",
            "@code": "1311"
        }
    ],
    "keywords": [
        "13:01",
        "dapsone-induced severe cutaneous adverse drug reactions",
        "HLA-B",
        "nonleprosy",
        "severe cutaneous adverse reactions",
        "Thai"
    ],
    "authors": [
        "Therdpong Tempark"
    ],
    "citedby-count": 82,
    "ref-count": 50,
    "ref-list": [
        "Severe cutaneous adverse reactions: Impact of immunology, genetics, and pharmacology",
        "Severe cutaneous adverse reactions (SCAR) syndromes",
        "Pharmacogenetics of cutaneous adverse drug reactions",
        "Drug reaction with eosinophilia and systemic symptoms (DRESS) / drug-induced hypersensitivity syndrome (DIHS): A review of current concepts",
        "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist?",
        "The DRESS syndrome: A literature review",
        "Drug reaction with eosinophilia and systemic symptoms (DRESS): A clinical update and review of current thinking",
        "Dapsone and sulfones in dermatology: Overview and update",
        "Increase in the incidence of dapsone hypersensitivity syndrome - An appraisal",
        "Dapsone syndrome in Vanuatu: A high incidence during multidrug treatment (MDT) of leprosy",
        "Dapsone hypersensitivity syndrome",
        "Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand",
        "Pharmacogenomics of drug-induced hypersensitivity reactions: Challenges, opportunities and clinical implementation",
        "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol",
        "Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir",
        "HLA and pharmacogenetics of drug hypersensitivity",
        "Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese",
        "J Allergy Clin Immunol",
        "Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions",
        "Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population",
        "Association between HLA-B*1301 and Dapsone-Induced Hypersensitivity Reactions among Leprosy Patients in China",
        "HLA-B*13:01 and the dapsone hypersensitivity syndrome",
        "Human leukocyte antigens in tuberculosis and leprosy",
        "The HLA Association of Lepromatous Leprosy and Borderline Lepromatous Leprosy in Turkey: A Preliminary Study",
        "Leprosy associated with HLA\u2010DR2 and DQwl in the population of northern Thailand",
        "HLA and leprosy in Koreans",
        "HLA-DRB1* 04 and DRB1* 10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients",
        "Human leukocyte antigens in forms of leprosy among Japanese patients",
        "Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians",
        "Association of HLA-DRB1*0405 with resistance to multibacillary leprosy in Taiwanese",
        "Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme",
        "Severe cutaneous adverse reactions to drugs (SCAR): Definitions, diagnostic criteria, genetic predisposition",
        "HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: Evidence for high risk of drug-induced hypersensitivity",
        "Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex",
        "How TCRs bind MHCs, peptides, and coreceptors",
        "Dapsone hypersensitivity syndrome among leprosy patients in China.",
        "Asia Pac Allergy",
        "Association of HLA-B1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population",
        "Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations",
        "Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population",
        "HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans",
        "HLA and the Pharmacogenomics of Drug Hypersensitivity",
        "Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back",
        "HLA allele frequencies in 5802 koreans: Varied allele types associated with SJS/TEN according to culprit drugs",
        "Molecular modeling study on dapsone and sulfonamides comparing structures and properties with respect to anti-leprosy activity",
        "Practical Issues in the Management of Hypersensitivity Reactions: Sulfonamides",
        "Dapsone Hypersensitivity: The Sulfone Syndrome Revisited",
        "Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective study",
        "Severe adverse cutaneous reactions to drugs",
        "A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Ramathibodi Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phayao",
            "affilname": "University of Phayao",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phrae",
            "affilname": "Phrae Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Faculty of Medicine, Ramathibodi Hospital",
        "Thailand Research Fund and University of Phayao",
        "Chulalongkorn University",
        "Mahidol University"
    ]
}